Secukinumab for Psoriasis in Obese Patients: Minireview and Clinical Experience
Psoriasis (PsO) has been associated with obesity, and its severity increases in obese subjects. The link between psoriatic condition and obesity is based on shared pathophysiological pathways where local and systemic inflammation promote each other; PsO is an inflammatory, immune-mediated disease, a...
Saved in:
Main Authors: | Rossana Tiberio (Author), Francesca Graziola (Author), Benedetta Miglino (Author), Federica Veronese (Author), Giordana Annali (Author), Paola Savoia (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing Secukinumab Treatment in Psoriasis with Concomitant Methotrexate Administration: Minireview and A Case Report
by: Dimitra Kostaki, et al.
Published: (2019) -
North Italy: Welcome to the Tropics!
by: Federica Veronese, et al.
Published: (2021) -
Secukinumab in psoriasis: A single-center experience
by: Esra Ağaoğlu, et al.
Published: (2021) -
Secukinumab in generalized pustular psoriasis
by: Shraddha Madanagobalane
Published: (2018) -
Secukinumab Therapy in Psoriasis Management
by: Ira Yunita, et al.
Published: (2022)